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SUMMARY
Peptidoglycan recognition proteins (PGRPs) are mediators of innate immunity and recently have
been implicated in developmental regulation. To explore the interplay between these two roles, we
characterized a PGRP in the host squid Euprymna scolopes (EsPGRP1) during colonization by the
mutualistic bacterium Vibrio fischeri. Previous research on the squid-vibrio symbiosis had shown
that, upon colonization of deep epithelium-lined crypts of the host light organ, symbiont-derived
peptidoglycan monomers induce apoptosis-mediated regression of remote epithelial fields
involved in the inoculation process. In this study, immunofluorescence microscopy revealed that
EsPGRP1 localizes to the nuclei of epithelial cells, and symbiont colonization induces the loss of
EsPGRP1 from apoptotic nuclei. The loss of nuclear EsPGRP1 occurred prior to DNA cleavage
and breakdown of the nuclear membrane, but followed chromatin condensation, suggesting that it
occurs during late stage apoptosis. Experiments with purified peptidoglycan monomers and with
V. fischeri mutants defective in peptidoglycan-monomer release provided evidence that these
molecules trigger nuclear loss of EsPGRP1 and apoptosis. The demonstration of a nuclear PGRP
is unprecedented, and the dynamics of EsPGRP1 during apoptosis provide a striking example of a
connection between microbial recognition and developmental responses in the establishment of
symbiosis.
INTRODUCTION
Peptidoglycan-recognition proteins, or PGRPs, are a protein family of innate immune
system effectors and receptors conserved across the animal kingdom (Zhang et al., 2007,
Coteur et al., 2007, Dziarski et al., 2006b, Werner et al., 2000, Goodson et al., 2005).
PGRPs mediate host responses to the bacterial cell-envelope component, peptidoglycan
(PGN). In-depth research on the PGRPs in the last 10 years has principally focused on
biochemical characterizations of the activity and binding specificity of the purified proteins,
as well as the genetics of their in vivo function in Drosophila melanogaster (Filipe et al.,
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2005, Park et al., 2007, Kaneko et al., 2004, Kaneko et al., 2006, Lim et al., 2006, Dziarski
et al., 2006a, Lu et al., 2006). For example, in vitro studies have demonstrated that the
characteristic PGRP domain binds specifically to PGN ligands (Swaminathan et al., 2006,
Chang et al., 2006) and in some isoforms also cleaves the substrate (Steiner, 2004). Genetic
analyses have implicated these behaviors in the regulation of downstream response
pathways (Michel et al., 2001, Kaneko et al., 2004, Bischoff et al., 2006).
These studies have defined similarities and differences among the vertebrates and
invertebrates. In both animal groups, some PGRPs can act to attenuate the inflammatory
response by degrading the PGN through N-acetyl-muramyl-L-alanine amidase (NAMLAA)
activity (Gelius et al., 2003, Zaidman-Remy et al., 2006, Bischoff et al., 2006), which
requires a cysteine residue in the PGN-binding pocket. In this enzymatic behavior, the stem
peptide is cleaved from the sugar backbone of PGN, resulting in products that are less
immunogenic (Bischoff et al., 2006). Although all mammalian PGRPs described thus far are
reported to be secreted proteins, the invertebrate homologs can act as receptors for PGN, a
feature reflected in their localization. The invertebrate PGRPs are predicted to be either
intracellular, membrane associated, or secreted (Royet et al., 2007), although few studies
have defined precise cellular localization (Gupta, 2008, Kaneko et al., 2006, Dziarski et al.,
2003). The more varied predicted localization of invertebrate PGRPs correlates with broader
function. In Drosophila, PGRPs have been implicated in the regulation of apoptosis and
development (Maillet et al., 2008, Bischoff et al., 2006), activation or dampening of the
immune response (Yoshida et al., 1996, Takehana et al., 2002, Kaneko et al., 2006, Kaneko
et al., 2004, Maillet et al., 2008), control of phagocytosis (Ramet et al., 2002), and as direct
immune effectors (Mellroth et al., 2006).
PGRPs have been implicated not only in mediating responses to microbial pathogens, but
also in the dynamics of mutualistic symbioses in invertebrates (Anselme et al., 2006,
Bischoff et al., 2006, Anselme et al., 2008). The binary association between the Hawaiian
bobtail squid Euprymna scolopes and the marine bacterium Vibrio fischeri has been used for
the last 20 years as a model for the study of mutualistic symbioses [for reviews see:
(Nyholm et al., 2004, Visick et al., 2006)]. The analysis of an EST database constructed
from the symbiotic tissues of juvenile E. scolopes revealed the expression of four host
PGRPs, EsPGRP1-4, in these bacteria-containing tissues (Goodson et al., 2005). This
finding suggested the squid-vibrio system could be a model for the study of these proteins in
mutualistic associations. In this naturally occurring, binary symbiosis, the partners can be
experimentally manipulated. This feature facilitates the discovery of the molecular
underpinnings of the cellular interactions between host and symbiont. In addition, molecular
genetics have been developed in V fischeri, providing the opportunity to study changes in
the host in response to genetic alterations in key symbiont characters (Visick et al., 2006).
A key feature of this symbiosis is its exclusivity: only V. fischeri is capable of colonizing
host tissues and inducing morphogenesis (McFall-Ngai et al., 1991). The exclusivity is
achieved through the multiple steps required for colonization, including competitive
dominance during aggregation in host mucus, locomotion to the light-organ pores, and
resistance to the oxidatively stressful environment of the ducts (Nyholm et al., 2004). V.
fischeri cells appear to signal morphogenesis from the light-organ interior, which is several
cell layers away from the tissue layer that regresses (Fig. 1) (Montgomery et al., 1994,
Doino et al., 1995). Thus, either the morphogenetic signals are sensed by the internal
epithelia and responses are transduced through the tissues to the superficial epithelium, or
the bacterial signal molecules are transported through host tissues to the sites of
morphogenesis where they would act directly on host cells. In either case, the development
is irreversibly triggered at 12 h and completed by 96 h (Doino et al., 1995).
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Studies of these early developmental events implicated the cell-envelope constituents of V.
fischeri, specifically derivatives of lipopolysaccharide (LPS) and PGN, in the triggering of
host tissue morphogenesis. V. fischeri is one of the few bacterial species known to release
the tetrapeptide peptidoglycan monomer, 'tracheal cytotoxin' (TCT) (Cloud-Hansen et al.,
2006, Rosenthal et al., 1987), which mediates the destruction of epithelial tissues in certain
pathogenic associations (Cookson et al., 1989, Cloud et al., 2002). Further, as stated above,
only V. fischeri can enter the crypts of E. scolopes to present these morphogens. Light organ
development can be triggered in the absence of V. fischeri by exposing juvenile squid to the
synergistic activity of TCT and the lipid A component of LPS (Koropatnick et al., 2004).
LPS alone fails to drive light organ development but will induce chromatin condensation
without progression into the later stages of apoptosis, such as DNA fragmentation (Foster et
al., 1998). When added as pharmacological agents, which are readily taken up into the crypt
spaces, TCT synergizes with LPS to mimic symbiont-induced chromatin condensation and
epithelial regression (Koropatnick et al., 2004). While the effects of TCT and LPS on late-
stage apoptosis were not investigated, this study led to the model that these biomolecules are
sufficient to induce light organ morphogenesis.
The finding that V. fischeri PGN is critical for morphogenesis, coupled with the discovery of
expression of PGRPs in the juvenile light organ, suggested that the EsPGRPs are good
candidates to mediate the host response to bacterial PGN products. EsPGRP1 is of particular
interest because its 107 expression is up-regulated during early morphogenesis (Chun et al.,
2008). The derived amino acid sequence and lack of a putative signal peptide predicted that
EsPGRP1 is a 23.5-kDa intracellular protein (Goodson et al., 2005). The presence of
conserved amino acid residues required for NAMLAA activity suggested EsPGRP1 has
PGN amidase activity.
In this study, we sought to describe the role of EsPGRP1 during early post-embryonic
development of the light organ. We observed this protein in host tissues of uncolonized
animals and during colonization by wild-type V. fischeri or by TCT-production mutants, as
well as during the host response to pharmacological exposure to PGN and LPS derivatives.
The data presented here provide evidence that PGRPs are components of the host response
to mutualistic microbial associations and are integral components of the developmental
response to bacterial cues in this symbiosis.
RESULTS
Characterization of the EsPGRP1 protein and an anti-EsPGRP1 antibody
Western blot analyses determined that EsPGRP1 is present in the soluble fraction of lysed
cells of whole newly-hatched animals. The EsPGRP1 antibody (Fig. 2A) reacted with a
peptide at ~24 kDa, consistent with the molecular mass predicted by the derived amino acid
sequence (Fig. 2B). To test the prediction that EsPGRP1 has amidase activity (Goodson et
al., 2005), we transfected a FLAG-tagged EsPGRP1 expression plasmid into Drosophila
S2* cells. A protein fraction enriched for EsPGRP1-FLAG was generated from these
transfectants using anti-FLAG affinity chromatography (Fig. 2C). This fraction was co-
incubated with TCT. Within 1 h, 64 ng of the EsPGRP1-enriched protein fraction degraded
over 2.5 µg of TCT (Fig. 2D), in a manner consistent with PGRP amidase activity (Gelius et
al., 2003). In contrast, 24 µg of crude protein extract of S2* cells was found to have no
catalytic activity against TCT. The potential for direct interaction between EsPGRP1 and
PGN was further supported by the appearance of zones of clearing on a PGN-gel zymogram
at positions corresponding to EsPGRP1-bands on a companion immunoblot (Fig. S1).
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EsPGRP1 localized to epithelial nuclei
To gain insight into the possible functions of EsPGRP1 in the symbiosis, we performed
confocal immunocytochemistry to localize the protein in tissues and cells. Reactivity to the
EsPGRP1 antibody occurred in the nuclei of epithelia throughout the body (Fig. 3, Fig S2),
including those of the light organ, gills, gut, and mantle. Unlike other epithelia, where
variation in staining intensity occurs among cells, nuclear localization of EsPGRP1 in the
superficial ciliated epithelium of the light organ was uniform from cell-to-cell in hatchling
and in non-symbiotic animals (n > 100 individuals, from the eggs of 10 different females)
(Fig. 3A–D). EsPGRP1 was detected at low levels in the connective tissue matrix of the
light organ, and when present, appeared to be entirely non-nuclear (Fig. 3B, D). The nuclear
distribution of EsPGRP1 was heterogeneous; anti-EsPGRP1 antibodies most intensely
stained sub-nuclear regions that were weakly labeled for nucleic acids (Fig. 3–Fig 6),
suggesting that EsPGRP1 does not directly bind to DNA. Pre-immune serum did not react
detectably with host tissues at comparable gain settings on the confocal microscope (Fig.
S3), and antibodies generated to the other three EsPGRPs did not show significant reactivity
in the nuclei (data not shown).
Absence of nuclear EsPGRP1 was correlated with symbiosis-induced late-stage apoptosis
in the light organ
To understand the function of EsPGRP1 during colonization, we first examined its
localization at 24 h. All morphogenic processes of the superficial light organ epithelia are
underway at this time. Whereas all epithelial cells of non-symbiotic animals stained
similarly, a subset of the epithelial nuclei in 24-h symbiotic light organs did not stain for
EsPGRP1 (Fig. 4A). The EsPGRP1-negative nuclei contained condensed chromatin, and
cells with these phenotypes occurred at a frequency similar to that observed previously for
apoptotic cells in the 24-h symbiotic light organ (Foster et al., 1998,Koropatnick et al.,
2004). These data suggested that EsPGRP1-negative nuclei occur in the cells undergoing
apoptosis. This hypothesis was supported by the finding that all nuclei undergoing DNA
degradation, i.e., were TUNEL positive, a characteristic of the later stages of programmed
cell death in this system (Foster et al., 1998), also lacked EsPGRP1 (Fig. 4B). The reverse
did not occur, i.e., only a subset of EsPGRP1-negative nuclei was TUNEL positive. These
observations provide evidence that nuclear loss of EsPGRP1 occurs prior to late-stage
apoptosis.
To determine the relationship of EsPGRP1 loss to the integrity of the nucleus during
apoptosis, we examined EsPGRP1 localization in the context of known nuclear apoptosis
events. We observed an alternate intra-nuclear distribution of EsPGRP1, in which the DNA
appeared condensed and EsPGRP1 appeared to fill the remainder of the nucleoplasm (Fig.
4C). The alternate EsPGRP1/DNA distribution was observed very rarely, suggesting that
this distribution is highly transient. In addition, we investigated the temporal/spatial
relationship between EsPGRP1 and nucleoporins, which during apoptosis undergo spatial
redistribution in the nuclear membrane and are eventually degraded (Kihlmark et al., 2001).
In EsPGRP1/nucleoporin co-staining experiments in symbiotic animals, EsPGRP1 was lost
from the nucleus prior to the redistribution and breakdown of the nucleoporins (Fig. 4D).
Taken together these data suggest that nuclear loss of EsPGRP1 rapidly follows chromatin
condensation and precedes the breakdown of the nuclear envelope, linking nuclear loss of
EsPGRP1 to the apoptotic pathway.
Timing of EsPGRP1 loss suggested a role in late-stage apoptosis and morphogenesis
As described above, all TUNEL-positive nuclei were EsPGRP1 negative while only a subset
of EsPGRP1-negative nuclei was TUNEL positive (Fig. 4B), suggesting that nuclear loss of
EsPGRP1 occurs prior to late-stage apoptosis. To characterize the timing of these processes,
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we enumerated EsPGRP1-negative and TUNEL-positive nuclei in anterior appendages from
both symbiotic and non-symbiotic light organs at the following time points: 8 h, 12 h, 13 h,
18 h and 24 h post hatching (Fig. 5A,B). The loss of nuclear EsPGRP1 was first detected in
symbiotic animals at 12 h, a time point coincident with the delivery of the irreversible signal
for morphogenesis. In addition, we observed significantly greater numbers of EsPGRP-
negative nuclei at 13 h, only 1 h after the morphogenesis signal. An increased level of
EsPGRP1-negative nuclei was present in symbiotic animals at each time point up to 24 h. In
contrast, TUNEL-positive nuclei were first detected in symbiotic light organs at 13 h, and
greater numbers were not observed until 18 h, followed by another significant increase at 24
h. Greater numbers of both EsPGRP1-negative (13–24 h) and TUNEL-positive (18–24 h)
nuclei were found in symbiotic compared to non-symbiotic light organs, consistent with
these events being components of colonization-induced morphogenic tissue destruction.
Beyond 24 h, cells were rapidly lost from the anterior appendage due to morphogenesis and
counts from these later time points cannot be compared to the earlier time points. These data
provide evidence that nuclear loss of EsPGRP1 precedes entry into late-stage apoptosis. As
it is not possible to follow an individual cell through the entire process, it cannot be ruled
out that a subset of EsPGRP1-negative nuclei never become TUNEL positive.
Because the onset of nuclear-EsPGRP1 loss coincided with the delivery of an irreversible
morphogenic signal by V. fischeri at 12 h (Doino et al., 1995), we hypothesized that the
EsPGRP1 phenotype was a component of the host response to this morphogenesis signal. To
test this hypothesis, we performed “curing” experiments to determine whether EsPGRP1
loss is also a component of the irreversible morphogenic program. In these experiments,
symbiotic juvenile E. scolopes were treated with the antibiotic chloramphenicol to clear the
crypts of symbionts either before or after the 12-h time point and were subsequently assayed
at 24 h (Fig. 5C). Previous experiments showed that only a small proportion of animals
cured before 12 h progressed through morphogenesis, whereas 100% of animals cured at 12
h or later underwent development (Doino et al., 1995). Light organs cured of V. fischeri
after 12 h were similar to fully symbiotic light organs with respect to nuclear loss of
EsPGRP1 and entry into late-stage apoptosis. In contrast, 100% of light organs cured before
12 h were protected from cell death and 80% were protected from loss of EsPGRP1. These
data implicate nuclear loss of EsPGRP1 in symbiotic light organs as a component of the
developmental response to the irreversible morphogenic signal delivered by V. fischeri.
TCT induced nuclear loss of EsPGRP1 in light organ tissues
Because TCT and LPS together irreversibly signal morphogenesis at 12 h (Koropatnick et
al., 2004), we performed experiments to determine whether TCT and LPS are sufficient to
trigger EsPGRP1 loss and entry into late-stage apoptosis. We took two approaches: (i)
pharmacological treatment with TCT and/or LPS (or its active component lipid A), and (ii)
colonization with V. fischeri mutants defective in TCT release. While treatment with V.
fischeri LPS had no effect on either the nuclear localization of EsPGRP1 or late-stage
apoptosis, the presence of 10 µM TCT induced a level of nuclear loss of EsPGRP1 close to
that characteristic of symbiotic tissues (Fig 6A, B). Unlike regression and hemocyte
trafficking 212 (Koropatnick et al., 2004), EsPGRP1 loss was not increased by the addition
LPS/lipid A with TCT (Fig. 6B). Because PGN monomers were not previously reported to
induce apoptosis in the squid light organ, we postulated that a small amount of LPS
contaminating the filter-sterilized Instant Ocean could have been synergizing with the TCT
to induce the levels EsPGRP1 loss and TUNEL-positive nuclei observed in all TCT
treatments. Alternatively, because EsPGRP1 directly interacted with PGN in vitro (Fig. 2), it
remained possible that this phenotype was distinct and dependent only on the presence of
PGN fragments, such as TCT. To address this matter, we included a control using a
polyclonal anti-LPS antibody to inhibit any effects from contaminating LPS as previously
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described (Koropatnick et al., 2004). The anti-LPS antibody had no statistically significant
effect on either nuclear loss of EsPGRP1 or the induction of TUNEL (Fig. 6B), suggesting
that all of the effects could be attributed to the activity of TCT. A mutant of V. fischeri
lacking three lytic-transglycosylase genes (Δltg), which is unable to release TCT in vitro
(Adin et al., 2008), did not induce full EsPGRP1 and TUNEL phenotypes by 24 h when
compared to wild-type colonized hatchlings (Fig. 6C). Some residual activity was observed
in light organs colonized by the Δltg mutant, which is likely due to PGN release during
normal symbiont cell turnover. Partial complementation of the triple mutant with either of
two single lytic-transglycosylase genes in trans restored phenotypes comparable to wild-
type colonized animals. The genetic data, coupled with pharmacological application of TCT,
conclusively demonstrate that peptidoglycan monomers are necessary for both normal
localization changes of EsPGRP1 and induction of late-stage apoptosis in the morphogenesis
program.
The TCT-induced loss of nuclear EsPGRP1 and late-stage apoptosis was limited to the light
organ epithelia. In addition to light organ tissues, we also examined the epithelia and
connective tissues of the gut, gills and epidermis. In the epithelia of these three tissues,
neither TCT treatment nor symbiosis was observed to have any effect on either the nuclear
localization of EsPGRP1 or the induction of apoptosis (Fig. 6A and Fig S2). We observed an
average of 4 TUNEL-positive epithelial cells per hindgut of non-symbiotic animals (n = 8).
Comparable levels of TUNEL-positive epithelial nuclei were found in hindguts from TCT-
treated animals (n = 7). Every TUNEL-positive epithelial nucleus lacked staining for
EsPGRP1, a characteristic that contrasted with nuclei from neighboring non-apoptotic gut
epithelial cells, which strongly stained for EsPGRP1. These data show that TCT is a specific
morphogen of the light organ and that other tissues are insensitive to its effects. In addition,
it appears that nuclear loss of EsPGRP1 is a common component of the apoptotic pathway in
E. scolopes epithelial cells whether they are responding to TCT or some alternate apoptotic
stimulus.
DISCUSSION
In this study, we characterized the cellular dynamics of EsPGRP1 in symbiont-induced
tissue destruction in the light organ of E. scolopes, a process in which apoptosis is a
hallmark character (Fig. 1C). We provide evidence that: 1) EsPGRP1 is a nuclear protein of
the E. scolopes epithelia; 2) in the light organ, the nuclear localization of EsPGRP1 is lost
during the course of symbiont-induced morphogenesis; 3) the alteration of EsPGRP1
localization is morphologically, temporally and spatially correlated with programmed cell
death as a component of light organ development; and 4) nuclear loss of EsPGRP1 and
subsequent entry into late-stage apoptosis are induced by the light organ morphogen, TCT,
implicating EsPGRP1 dynamics in light-organ development.
The nuclear localization of EsPGRP1 is unprecedented and, to our knowledge, no other
PGRPs have been reported to localize to the nucleus. While the EsPGRP1 protein contains
no obvious nuclear localization signals, some proteins with molecular weights less than ~50
kDa can passively diffuse into the nucleus (Talcott et al., 1999). Passive diffusion alone
would likely result in an even distribution of protein between the cytoplasm and the nucleus.
However, EsPGRP1 concentrates in the nucleus relative to the cytoplasm. This uneven
distribution suggests that some mechanism other than passive diffusion must also contribute
to the cellular localization of EsPGRP1, e.g., binding to nuclear elements may be
responsible for sequestering EsPGRP1, or EsPGRP1 may specifically bind to an unknown
protein with a strong nuclear localization signal resulting in nuclear import.
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Multiple lines of evidence tie the nuclear localization dynamics of EsPGRP1 to the apoptotic
process. EsPGRP1 was lost from nuclei with morphologies consistent with apoptosis, and
these EsPGPR1-negative nuclei occurred with a frequency similar to that observed for
apoptotic cells during light organ morphogenesis (Foster et al., 1998, Koropatnick et al.,
2004, Foster et al., 2000). All TUNEL-positive nuclei were EsPGRP1 negative and loss of
nuclear EsPGRP1 occurred shortly after chromatin condensation, and prior to the re-
distribution and breakdown of nucleoporins (Fig. 4). The timing of EsPGRP1 loss from the
nucleus was consistent with that reported for apoptosis in the light organ. Chromatin
condensation peaks between 12 h and 14 h (Foster et al., 1998) and the nuclear loss of
EsPGRP1 was first observed to increase significantly in this time frame (Fig. 5). Further, we
observed the onset of nuclear loss of EsPGRP1 consistently ahead of the onset of DNA
cleavage (TUNEL) suggesting that removal of EsPGRP1 is permissive to apoptotic
progression (Fig. 5). The timing of DNA cleavage observed in this study, using a
fluorometric TUNEL assay, is consistent with the previously published timing of DNA
cleavage and late-stage apoptosis in the light organ based on observations of cellular
morphology and colorimetric TUNEL assays in histological sections (Foster et al., 1998,
Montgomery et al., 1994). Thus, the timing described here is unlikely to be due to
differences in sensitivity of the TUNEL and EsPGPR1 nuclear loss assays. We conclude that
nuclear loss of EsPGRP1 occurs during the apoptotic process, following chromatin
condensation and preceding reorganization of the nuclear envelope and DNA cleavage.
An association between PGRPs and apoptosis has begun to gain recognition. Genetic studies
of PGRPs have revealed that they can both activate and be activated by the transcription
factor NF-κB, a known regulator of apoptosis (Michel et al., 2001, Kaneko et al., 2004,
Lang et al., 2008, Beg et al., 1996). Drosophila PGRP-LF mutants are developmentally
defective in wing formation, including the aberrant appearance of apoptotic cells in the wing
imaginal discs (Maillet et al., 2008). The correlation of EsPGRP1 activity and apoptosis
within E. scolopes epithelial cells further supports the relationship between the PGRP family
of innate immunity proteins and animal development through control and/or interaction with
apoptosis pathways.
In experiments with bacterial cell-envelope components known to induce morphogenesis in
the light organ, TCT was capable of inducing a full EsPGRP1 response with little or no
contribution from lipid A or LPS. However, treatment with TCT or TCT + LPS failed to
induce the full apoptotic response that is induced by V. fischeri, i.e., including late stage
apoptosis as visualized by TUNEL (Fig. 6B). Earlier studies of apoptosis induction by TCT
+ LPS used an early-stage cell-death indicator, chromatin condensation visualized by
acridine orange staining (Koropatnick et al., 2004). In that study, a dose response analysis
was performed to determine the concentrations of TCT + LPS that most closely mimicked
the onset of cell death by the symbiont, which provided the basis for concentrations used in
the present study. Thus, it is likely that the failure of the TCT + LPS to induce the full
program is not due to their concentration. However, subtle differences may exist in the way
these molecules are presented by intact bacteria compared to pharmacological treatment,
such that purified cell-envelope constituents are fully capable of inducing early-stage, but
not late-stage, apoptosis. Alternatively, the symbionts may be providing a third morphogenic
signal, which complements TCT + LPS under natural conditions.
Candidates for additional morphogenic signals include other cell surface molecules of the
symbiont, such as the flagellins and the Syp exopolysaccharide, both of which are important
early in colonization (Millikan et al., 2004, Yip et al., 2005). Symbiont luminescence,
another possible signal, has been shown to have specific effects on morphogenesis.
Bioluminescence is induced following colonization of the deep crypts. V. fischeri luxA
mutants, which fail to produce light, are attenuated in their ability to induce host hemocyte
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trafficking (Koropatnick et al., 2007) and cell swelling (Visick et al., 2000), and are delayed
in regression (unpublished data, Koropatnick and McFall-Ngai). It is intriguing to speculate
that the slowed morphogenesis in animals colonized by luxA mutants could be due to a
reduction in the speed of apoptosis due to the lack of symbiotic bioluminescence. Future
studies will investigate whether dark mutants of V. fischeri are also deficient in their
induction of the nuclear loss of EsPGRP1 and late-stage apoptosis.
Microarray studies of the onset of the symbiosis revealed that ESPGRP1 mRNA levels are
increased at 18 h following inoculation in animals colonized by V. fischeri, i.e., concurrent
with the loss of EsPGRP1 from the nuclei of the superficial epithelial field. In addition, luxA
mutants fail to induce the full increase in EsPGRP1 transcript levels characteristic of
colonization with wild-type V. fischeri (Chun et al., 2008). The findings that the luxA
mutants are delayed in regression and show lower levels of EsPGRP1 mRNA suggest that
these symbiont-triggered increases in EsPGRP1 gene transcription are important for the
induction of full morphogenesis. How this up-regulation interfaces with the eventual loss of
the protein from the nuclei of the cells of the superficial epithelial field remains to be
determined.
It is unclear whether the activity of TCT is the result of a direct interaction with EsPGRP1 or
works through an intermediary receptor/signal transduction pathway. Genetic evidence from
D. melanogaster suggests TCT can be transported across host cell membranes (Kaneko et
al., 2006), so it is conceivable that TCT could gain access to the cytoplasm and the nucleus,
via passive diffusion, of light organ epithelial cells. We attempted to determine the location
of TCT in host tissue through a suite of approaches including confocal microscopy of
hatchling E. scolopes treated with FITC-labeled TCT (data not shown) (Flak et al., 1998)
and NanoSIMS tracing of stable isotope labeled TCT (Fig. S4) (Lechene et al., 2006). To
our knowledge, the localization of TCT in host cells has not been accomplished in any
system. In the present study, we were unable to detect TCT associated with the host tissue.
However, apoptotic cells in tissues that are unresponsive to TCT undergo nuclear loss of
EsPGRP1, suggesting that this process is a component of apoptosis, independent of TCT
induction. Thus, it seems unlikely that EsPGRP1 is responding directly to TCT. EsPGRP4 is
an obvious candidate for a TCT-receptor because this protein is expressed in the light organ,
contains a putative transmembrane domain, and topology prediction programs suggest that
the PGRP domain would be localized on the extracellular membrane surface (Goodson et
al., 2005). However, the cytoplasmic domain of this putative integral membrane protein is
small, providing few clues as to possible downstream signaling pathways that could
potentially result in activation of apoptosis and morphogenesis. Recently, an intranuclear
bacterial pathogen of bivalve mollusks, Candidatus Endonucleobacter bathymodioli, was
characterized (Zielinski et al., 2009), suggesting a selection pressure that could explain the
nuclear localization of EsPGRP1. It is easy to envision that rapidly inducing apoptosis upon
intranuclear invasion by a pathogen would limit the infectious potential of such a pathogen
by inhibiting its access to the energy-rich molecules of the nucleus. In such a scenario, it
would seem likely that this immune associated apoptosis was co-opted for developmental
regulation during the establishment of the squid/vibrio mutualism.
Whereas this is the first report of a nuclear PGRP associated with apoptosis, we expect that
this phenomenon is not unique. An interesting avenue for further research will be the
determination of mechanistic link to apoptosis. We predict that future studies of intracellular
localization of PGRPs among the marine invertebrates will reveal other nuclear members of
the PGRP protein family. Further, while the study of PGRPs has primarily focused on their
roles in ameliorating pathogenesis, we demonstrate a role for these proteins in mutualistic
associations of animals with their bacterial partners.
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Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Adult E. scolopes were caught in shallow coastal waters of Oahu and maintained and bred in
the lab as previously described (Montgomery et al., 1993). Juvenile squid used in
experiments were collected within 10 min of hatching, washed 3 times in filter sterilized
Instant Ocean (FSIO), and placed in scintillation vials containing either FSIO (non-
symbiotic) or FSIO + 5×103 cfu/ml of V. fischeri ES114 grown in LBS or SWT broth at
28°C (symbiotic). The Δltg mutant (ES114-derivative strain DMA388: ΔltgA, ΔltgD,
ltgY::erm) and its derivatives were used at 2×103 CFU/ml (Adin et al., 2008). In these
experiments, ES114 was used at identical concentrations to V. fischeri mutants. All animal
experiments were carried out on a 12-h light/dark cycle and colonization by V. fischeri was
monitored by following luminescence using a TD-20/20 luminometer (Turner Designs,
Sunnyvale, CA) (Ruby et al., 1993).
In experiments in which animals were cured of their symbionts, symbiotic juveniles were
exposed 364 to 20 µg/ml of chloramphenicol in FSIO beginning at 8.5 h or 14 h post
colonization (Doino et al., 1995) and were scored at 24 h post colonization. Non-symbiotic
juveniles exposed to chloramphenicol were also analyzed as a control for any effects of the
antibiotic on EsPGRP1. For experiments involving bacterial cell envelope components,
juvenile E. scolopes were exposed to 10 µM TCT and/or 10 ng/ml of either V. fischeri LPS
or lipid A in FSIO for 24 h. Cell envelope components were purified from V. fischeri as
previously described (Cookson et al., 1989, Apicella et al., 1994).
Antibody generation and western blots
Rabbit polyclonal antibodies were raised against an EsPGRP1 synthetic peptide conjugated
to ovalbumin (Harlan Biosciences, Indianapolis, IN). The synthetic peptide of 13 amino
acids, WSHYGLRNHNKSA, was selected from the C-terminal region of EsPGRP1 because
it is predicted to be highly antigenic (Lasergene Protean, DNA Star, Madison, WI) and
because it contains little similarity to the other EsPGRPs (Fig. 2A, Fig S1) or other
sequences in the light organ EST database. Upon western blot analysis to test the specificity
of the antisera for the EsPGRP1 antigen, squid tissues were homogenized in 20 mM sodium
phosphate pH 7.4, 100 mM sodium chloride. The aqueous soluble or cytosolic fraction was
obtained as the supernatant of a centrifugation of the sample at 14,000 × g for 15 min. The
pellet was then washed 3 times with the homogenization buffer and the membranes were
extracted with homogenization buffer containing 1% SDS. Protein concentrations were
determined using the Bradford assay. The proteins were then separated on 12.5% SDS-
PAGE gel and blotted onto a PVDF membrane (Bio-Rad, Hercules, CA). The blot was
blocked overnight in 20 mM Tris, pH 7.4, 300 mM sodium chloride, 5% bovine serum
albumin (BSA), and 1% goat serum (Jackson ImmunoResearch Labs, West Grove, PA).
Anti-EsPGRP1 antibody was diluted 1:100 in the block solution and incubated with the blot
overnight at room temperature. The blot was then incubated with the secondary antibody, a
goat anti- rabbit horseradish peroxidase-conjugate (Jackson ImmunoResearch Labs, West
Grove, PA) at a 1:3000 dilution. Reactivity was visualized using Pierce ECL
Chemiluminescent Western Blot kit (Pierce, Rockford, IL).
TCT degradation assays
The EsPGRP1 coding sequence was PCR amplified with a C-terminal FLAG-tag using the
following DNA primers: JT73,
ACAGTGGATCCATGCACCATCACCATCACCATATGCACGCGTTCGGAG; and
JT74,
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TT. The PCR product was subsequently cloned into the pPAC-PL plasmid using the BamHI
and NotI restriction enzymes. Plasmid pJT28 was constructed by subcloning the FLAG-
tagged EsPGRP1 coding sequence into the pRmHa-3 expression plasmid downstream of a
Cu2+-inducible metallothionien promoter by EcoRI and SalI restriction of the PCR product
of the following primers: JT136,
TACTTGAATTCATGCACCATCACCATCACCATATGCACGCGTTCG; and JT134,
ACTCTGTCGACTTATTTATCGTCATCGTCTTTGTAGTC. Drosophila S2* cells were
stably transfected with pJT28 as previously described (Silverman et al., 2000). EsPGRP1
protein was induced by addition of 500 µM CuSO4 into the media for 8–12 hours. Cells
were then harvested, washed with PBS and frozen at −80°C.
The Cu2+-induced pJT28/S2* cells were resuspended in lysis buffer (20 mM Tris, pH 7.4,
protease inhibitor cocktail III and 1mM PMSF) and incubated on ice for 10 min. Sodium
chloride was then added to a final concentration of 100 mM and the insoluble material was
separated by centrifugation at 20,000 × g for 10 min at 4°C. The supernatant was passed
over an anti-FLAG antibody affinity column three times and the column was subsequently
washed with 500 column volumes of TBS (20 mM Tris, pH 7.4, 150 mM Sodium chloride).
Bound proteins were eluted from the column with 100 µM FLAG-peptide. Fractions
containing high levels of the EsPGRP1 protein were determined by anti-FLAG
immunoblots. These fractions were combined and dialyzed against storage buffer (20 mM
Tris, pH 7.4, 300 mM Sodium chloride, 1mM DTT and 50% glycerol) and 411 stored at
−20°C. Anti-FLAG immunoblots were performed as above except using using 4% non-fat
dry milk/TBS as the blocking solution and a 1:1,000 dilution of rabbit polyclonal anti-FLAG
antibodies for 1 h at room temperature.
To perform the TCT-degradation assay, ~370 ng of the FLAG-purified EsPGRP1 protein
fraction was diluted into 500 µL of reaction buffer (50 mM ammonium acetate, pH 7, 550
mM Sodium chloride, 4 µM ZnSO4 and 1% BSA) and concentrated to 9.2 ng/µL on a 3-kDa
molecular weight cutoff microcon column (Millipore, Billerica, MA). 64 ng of the EsPGRP1
protein fraction was mixed 1:1 with 1mM TCT. The reaction was incubated at room
temperature for 1 h, diluted with 86 µL HPLC-grade water and loaded onto a Betasil C18
reverse phase column (Thermo Hypersil-Keystone, Bellefonte, PA). The TCT was
mobilized using a 0–15% acetonitrile gradient and detected by absorbance at 215 nm. The
crude S2* cell protein extract was generated as above, excluding the anti-FLAG affinity
fractionation step. To control for S2* cell-derived amidase activity, which could be
contaminating the EsPGRP1-enriched protein fraction, 24 µg of the crude S2* cell protein
extract was incubated with TCT for 2 h.
Immunocytochemical detection of EsPGRP1 in E. scolopes tissues
Unless otherwise noted, all fluorophores were obtained from Molecular Probes (Invitrogen,
Carlsbad, CA). To prepare juvenile squid for immunocytochemistry, they were
anaesthetized in FSIO + 2% ethanol and fixed with 4% paraformaldehyde in mPBS (50 mM
sodium phosphate, pH 7.4, 0.45M sodium chloride) for 18 h at 4°C. Post-fix samples were
kept at 4°C throughout the remainder of the protocol. Fixed squid were washed 4 times for
30 min in mPBS. The light organs were removed from each juvenile, permeabolized with
1% Triton-X-100 in mPBS (mPBST) for 2 days and then blocked overnight (mPBST, 0.5%
BSA, 1% goat serum). Light organs were then exposed to the EsPGRP1 antisera diluted
1:1000 in the block solution for 7 days. Light organs were washed 4 times for 1 h each wash
with mPBST and incubated overnight again in blocking solution. Samples were then
exposed overnight to fluorescent goat anti-rabbit antibody conjugates (FITC or TRITC,
Jackson ImmunoResearch Labs; AlexaFluor 633) diluted 1:25 in blocking solution
overnight. To counterstain the actin cytoskeleton, light organs were incubated with 165 nM
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Alexa Fluor 633-phalloidin in mPBST overnight. To counterstain nuclear DNA, light organs
were incubated with 100 µg/ml RNaseA in 2×SSC (30 mM sodium citrate, pH 7.2, 300 mM
sodium chloride) for 30 min at 37°C and then stained with either 1.5 µM propidium iodide
for 5 min or 2 µM TOTO-3 for 30 min at room temperature. Apoptotic chromosomal
cleavage was detected using the DeadEnd Fluorimetric TUNEL Assay kit (Promega,
Madison, WI) according to manufacturer’s instructions. The nuclear pore complex was
visualized by immunocytochemistry as above, except the anti-nucleoporin mAb 414
(Covance Research Products, Denver PA) was co-diluted 1:1000 with the anti-PGRP1 Ab.
Light organs were mounted in Vectashield anti-bleaching medium (Vector Labs,
Burlingame, CA) and viewed on an LSM510 laser scanning confocal microscope (Carl Zeiss
Microimaging, Thornwood, NY).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Events in the early symbiosis of the squid/vibrio association
A) A dorsal view of a hatchling E. scolopes. E. scolopes harvests V. fischeri cells from
ambient seawater within hours of hatching and maintains a population of the symbiont in a
specialized ‘light organ’. The light organ appears as a dark region in the center of the body
cavity (white arrow). B) A diagram depicting the ventral view of the hatchling light organ;
left of the dashed line surface features are shown, right of the dashed line interior structures
are displayed. Ciliated epithelial fields specific to the surface of the juvenile light organ
promote colonization by the symbiont. These ciliated epithelial fields that undergo
morphogenesis include the anterior appendage (aa), the posterior appendage (pa), and the
ciliated ridge (cr). C) A timeline illustrating relevant characteristics of the early symbiosis.
V. fischeri cells aggregate near the ciliated epithelial fields and enter the light organ around
4 to 6 hours post hatching. Within hours of successful colonization of the deep crypts of the
light organ, the symbionts deliver an irreversible signal that triggers an extensive
developmentally-programmed tissue destruction (morphogenesis) of the light organ into a
mature form lacking the ciliated epithelial fields. ac, antechamber; d, ducts; dc, deep crypts;
EPS, exopolysaccharide; hg, hindgut; LPS, lipopolysaccharide; p, pores; and PGN,
peptidoglycan.
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Figure 2. Biochemical characteristics of the EsPGRP1 protein
A) An alignment of the EsPGRP C-termini (arrow indicates additional C-terminal sequence
for EsPGRP3). Boxed area highlights antigen sequence used for anti-EsPGRP1 antibody
generation. *, identical residues; :, conserved substitutions; ., semi-conserved substitutions.
B) A representative immunoblot of E. scolopes tissue. The anti-EsPGRP1 antibody reacts
with a major band in the aqueous soluble fraction at ~24 kDa. C, cytoplasmic (aqueous)
fraction; M, membrane (SDS soluble) fraction. C) Anti-FLAG immunoblot and companion
gel of 24 µg crude protein extract from untransfected Drosophila S2* cells and 256 ng of an
EsPGRP1-enriched fraction of S2* cells transfected with an EsPGRP1-FLAG expression
construct. The arrow indicates an anti-FLAG reactive band at the expected molecular weight
for EsPGRP1. D) An EsPGRP1 enriched EsPGRP1/S2* fraction degraded TCT in vitro, but
a protein extract of untransfected S2* cells had no effect on TCT levels. Bars indicate mass
of TCT (left axis) in each reaction, white peaks inside bars are the TCT peaks following
treatment as the absorbance at 215nm on a reverse-phase HPLC chromatograph (right axis).
UnT/S2*, untransfected S2* cell extract +; EsPGRP1/S2*, EsPGRP1-enriched fraction of
S2* cells transfected with pJT28; mock rxn, TCT incubated in reaction buffer for 3 h; TCT,
7 µL 1mM TCT loaded directly onto HPLC column.
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Figure 3. Localization of EsPGRP1 in host tissue
Confocal immunocytochemistry of hatchling and 24-h non-symbiotic E. scolopes localized
EsPGRP1 to epithelial nuclei.
A) A low magnification image of the light organ. Anti-EsPGRP1 antibodies intensely
labeled the ciliated epithelial fields on the lateral surfaces of the light organ. B–D)
Representative higher magnification images displaying the anterior appendage and a portion
of the more medial ciliated field (dashed box in A). The nuclei of these epithelial cells (aa
and cr) labeled strongly with the anti-EsPGRP1 antibody (green arrows), whereas non-
epithelial nuclei of the underlying tissues (ctm) appeared devoid of EsPGRP1 (white
arrowheads). E) Epithelia across the body contain nuclear EsPGRP1. A representative image
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taken from gill tissue is shown, note variations of staining intensity in the nuclei (white
arrows). aa, anterior appendage; cr, ciliated ridge; ctm, connective tissue matrix; hg,
hindgut; p, pores; pa, posterior appendage. EsPGRP1, green; DNA, red; and actin
cytoskeleton, blue.
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Figure 4. Loss of EsPGRP1 during progression through apoptosis
Confocal microscopy of symbiotic light organs revealed nuclear loss of EsPGRP1 and entry
into late-stage apoptosis in anterior appendage epithelial nuclei.
A) Micrographs of an optical section of the anterior appendage; individual channels on the
left, merged image on the right. Colonization of the light organ by V. fischeri for 24 h
induces a subset of nuclei in the ciliated epithelial fields to lose EsPGRP1 staining (e.g.,
white arrowheads). B) High magnification micrographs of epithelial cells from the anterior
appendage. TUNEL staining of cleaved DNA only occurs in nuclei that have lost EsPGRP1
staining (yellow arrows), but not all EsPGRP1-negative nuclei are TUNEL positive (white
arrowhead). Dashed box in inset indicates area of the anterior appendage shown in high
magnification. C) Micrograph of an anterior appendage. Dashed box indicates area of high
magnification in right panel that displays a transient alteration of intranuclear (based on size
and shape) localization of EsPGRP1 staining after chromatin condensation but prior to the
loss of EsPGRP1-signal from the nucleus (yellow arrowhead) as seen in A. Note also that
hemocytes (h), which have migrated to the light organ blood sinus, fail to stain with
EsPGRP1. Color palette is the same as in B: EsPGRP1, green; DNA, Red; and TUNEL,
Blue. D) High magnification micrographs of anterior appendage epithelial cells from non-
symbiotic and symbiotic animals. Labeling of the nucleoporins (red) with the monoclonal
Ab 414 indicates that loss of EsPGRP1 from the nucleus (blue) occurs prior to the
dissolution of the nuclear membrane (red arrowheads). Inset in sym panel exhibits an
EsPGRP1-negative nucleus with complete breakdown of the nuclear envelope.
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Figure 5. The timing of EsPGRP1 nuclear loss
EsPGRP1 loss occurs before entry into late-stage apoptosis and is triggered by the
irreversible morphogenesis signal.
A) Representative confocal micrographs from a timecourse of 8–24 h symbiotic and non-
symbiotic hatchlings. EsPGRP1, green; DNA, red; and TUNEL, blue. B) Direct-count
estimates of EsPGRP1-negative nuclei (black bars) and TUNEL-positive nuclei (grey bars)
per anterior appendage (n=15). Statistical analysis included ANOVA with Tukey’s pairwise
comparisons to identify statistically significant differences between time points (group error
rate p ≤ 0.05). Symbols represent groupings that are statistically different from other groups.
Error bars represent standard error. C) A qualitative comparison of light organs from a
“curing experiment.” Symbiotic hatchlings were treated at 8.5 h or 14 h with 20 µg/ml
chloramphenicol and scored for EsPGRP1-negative and TUNEL-positive nuclei in the
anterior appendage at 24 h. The 95% confidence intervals (CI) for EsPGRP1-negative and
TUNEL-positive nuclei were determined for 24-h symbiotic animals and the values for each
animal from the two cured and the non-symbiotic groups were compared to the 24-h sym CI.
If the number of EsPGRP1-negative or TUNEL-positive nuclei in a given anterior
appendage fell within the 24-h sym CI, then that animal was considered “sym-type” for that
category (protein localization or cell-death).
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Figure 6. TCT induction of EsPGRP1 loss and late-stage apoptosis
A) Representative confocal micrographs of E. scolopes epithelia. Hatchling E. scolopes
were exposed to 10 ng/ml LPS and/or 10 µM TCT and assayed for EsPGRP1-negative and
TUNEL-positive nuclei at 24 h. TCT induces EsPGRP1-negative (white arrowheads) and
TUNEL-positive (yellow arrows) nuclei. EsPGRP1, green; DNA, red; TUNEL, blue. B)
Direct-count estimates of EsPGRP-negative and TUNEL-positive nuclei in TCT/LPS treated
light organs (n = 10). Symbols represent groupings that are statistically different from other
groups. C) Direct-count estimates of EsPGRP1-negative and TUNEL-positive nuclei in light
organs colonized by V. fischeri mutants defective in TCT secretion. Δltg represents mutant
strain DMA388, which is defective for three lytic transglycosylases (ΔltgA, Δ ltgD,
ltgY::erm). Complementation strains carry indicated gene on the plasmid pVSV107 (Dunn
et al., 2006). Symbols represent groupings that are statistically different from non-symbiotic
light organs († represents an intermediate level of EsPGRP1 loss that is different from both
sym and non-sym). For both B and C, Statistical analysis included ANOVA with Tukey’s
pairwise comparisons to identify statistically significant differences between time points
(group error rate p ≤ 0.05). Error bars represent standard error.
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